Your browser doesn't support javascript.
loading
Low- versus Standard-Dose Intravenous Tissue-Type Plasminogen Activator for Acute Ischemic Stroke: An Updated Meta-Analysis.
Liu, Huihui; Zheng, Huaguang; Cao, Yongjun; Pan, Yuesong; Wang, David; Zhang, Runhua; You, Shoujiang; Zhang, Xinmiao; Li, Shuya; Tong, Xu; Liu, Chun-Feng; Wang, Yilong.
Affiliation
  • Liu H; Department of Neurology and Suzhou Clinical Research Center of Neurological Disease, Second Affiliated Hospital of Soochow University, Suzhou, China. Electronic address: liuchunfeng@suda.edu.cn.
  • Zheng H; Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China; China National Clinical Research Center for Neurological Diseases, Beijing, China; Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China; Beijing Key Laboratory of Translational Medicine
  • Cao Y; Department of Neurology and Suzhou Clinical Research Center of Neurological Disease, Second Affiliated Hospital of Soochow University, Suzhou, China.
  • Pan Y; Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China; China National Clinical Research Center for Neurological Diseases, Beijing, China; Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China; Beijing Key Laboratory of Translational Medicine
  • Wang D; Illinois Neurological Institute Stroke Network, Sisters of the Third Order of St. Francis Healthcare System, University of Illinois College of Medicine, Peoria, Illinois.
  • Zhang R; Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China; China National Clinical Research Center for Neurological Diseases, Beijing, China; Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China; Beijing Key Laboratory of Translational Medicine
  • You S; Department of Neurology and Suzhou Clinical Research Center of Neurological Disease, Second Affiliated Hospital of Soochow University, Suzhou, China.
  • Zhang X; Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China; China National Clinical Research Center for Neurological Diseases, Beijing, China; Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China; Beijing Key Laboratory of Translational Medicine
  • Li S; Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China; China National Clinical Research Center for Neurological Diseases, Beijing, China; Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China; Beijing Key Laboratory of Translational Medicine
  • Tong X; Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China; China National Clinical Research Center for Neurological Diseases, Beijing, China; Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China; Beijing Key Laboratory of Translational Medicine
  • Liu CF; Department of Neurology and Suzhou Clinical Research Center of Neurological Disease, Second Affiliated Hospital of Soochow University, Suzhou, China.
  • Wang Y; Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China; China National Clinical Research Center for Neurological Diseases, Beijing, China; Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China; Beijing Key Laboratory of Translational Medicine
J Stroke Cerebrovasc Dis ; 27(4): 988-997, 2018 Apr.
Article in En | MEDLINE | ID: mdl-29224744
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Thrombolytic Therapy / Brain Ischemia / Tissue Plasminogen Activator / Stroke / Fibrinolytic Agents Type of study: Clinical_trials / Etiology_studies / Risk_factors_studies / Systematic_reviews Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: J Stroke Cerebrovasc Dis Journal subject: ANGIOLOGIA / CEREBRO Year: 2018 Type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Thrombolytic Therapy / Brain Ischemia / Tissue Plasminogen Activator / Stroke / Fibrinolytic Agents Type of study: Clinical_trials / Etiology_studies / Risk_factors_studies / Systematic_reviews Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: J Stroke Cerebrovasc Dis Journal subject: ANGIOLOGIA / CEREBRO Year: 2018 Type: Article